BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31914418)

  • 21. Cas4 Facilitates PAM-Compatible Spacer Selection during CRISPR Adaptation.
    Kieper SN; Almendros C; Behler J; McKenzie RE; Nobrega FL; Haagsma AC; Vink JNA; Hess WR; Brouns SJJ
    Cell Rep; 2018 Mar; 22(13):3377-3384. PubMed ID: 29590607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prespacer processing and specific integration in a Type I-A CRISPR system.
    Rollie C; Graham S; Rouillon C; White MF
    Nucleic Acids Res; 2018 Feb; 46(3):1007-1020. PubMed ID: 29228332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cas4 Nucleases Can Effect Specific Integration of CRISPR Spacers.
    Zhang Z; Pan S; Liu T; Li Y; Peng N
    J Bacteriol; 2019 Jun; 201(12):. PubMed ID: 30936372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foreign DNA capture during CRISPR-Cas adaptive immunity.
    Nuñez JK; Harrington LB; Kranzusch PJ; Engelman AN; Doudna JA
    Nature; 2015 Nov; 527(7579):535-8. PubMed ID: 26503043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA binding specificities of Escherichia coli Cas1-Cas2 integrase drive its recruitment at the CRISPR locus.
    Moch C; Fromant M; Blanquet S; Plateau P
    Nucleic Acids Res; 2017 Mar; 45(5):2714-2723. PubMed ID: 28034956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymmetric positioning of Cas1-2 complex and Integration Host Factor induced DNA bending guide the unidirectional homing of protospacer in CRISPR-Cas type I-E system.
    Yoganand KN; Sivathanu R; Nimkar S; Anand B
    Nucleic Acids Res; 2017 Jan; 45(1):367-381. PubMed ID: 27899566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling Exogenous DNA Processing in Cas4-Lacking Crispr Systems: A Novel Bypass Pathway Explored.
    Su X; Jin X; Wang Z; Duan S
    Adv Biol (Weinh); 2024 Mar; 8(3):e2300454. PubMed ID: 38072634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity.
    Nuñez JK; Kranzusch PJ; Noeske J; Wright AV; Davies CW; Doudna JA
    Nat Struct Mol Biol; 2014 Jun; 21(6):528-34. PubMed ID: 24793649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation.
    Musharova O; Klimuk E; Datsenko KA; Metlitskaya A; Logacheva M; Semenova E; Severinov K; Savitskaya E
    Nucleic Acids Res; 2017 Apr; 45(6):3297-3307. PubMed ID: 28204574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR-Cas adaptation in Escherichia coli.
    Mitić D; Bolt EL; Ivančić-Baće I
    Biosci Rep; 2023 Mar; 43(3):. PubMed ID: 36809461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.
    Vorontsova D; Datsenko KA; Medvedeva S; Bondy-Denomy J; Savitskaya EE; Pougach K; Logacheva M; Wiedenheft B; Davidson AR; Severinov K; Semenova E
    Nucleic Acids Res; 2015 Dec; 43(22):10848-60. PubMed ID: 26586803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation.
    Künne T; Kieper SN; Bannenberg JW; Vogel AI; Miellet WR; Klein M; Depken M; Suarez-Diez M; Brouns SJ
    Mol Cell; 2016 Sep; 63(5):852-64. PubMed ID: 27546790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-Cas adaptation in Escherichia coli requires RecBCD helicase but not nuclease activity, is independent of homologous recombination, and is antagonized by 5' ssDNA exonucleases.
    Radovcic M; Killelea T; Savitskaya E; Wettstein L; Bolt EL; Ivancic-Bace I
    Nucleic Acids Res; 2018 Nov; 46(19):10173-10183. PubMed ID: 30189098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Functional Mini-Integrase in a Two-Protein-type V-C CRISPR System.
    Wright AV; Wang JY; Burstein D; Harrington LB; Paez-Espino D; Kyrpides NC; Iavarone AT; Banfield JF; Doudna JA
    Mol Cell; 2019 Feb; 73(4):727-737.e3. PubMed ID: 30709710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prespacers formed during primed adaptation associate with the Cas1-Cas2 adaptation complex and the Cas3 interference nuclease-helicase.
    Musharova O; Medvedeva S; Klimuk E; Guzman NM; Titova D; Zgoda V; Shiriaeva A; Semenova E; Severinov K; Savitskaya E
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34035168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DnaQ exonuclease-like domain of Cas2 promotes spacer integration in a type I-E CRISPR-Cas system.
    Drabavicius G; Sinkunas T; Silanskas A; Gasiunas G; Venclovas Č; Siksnys V
    EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29891635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
    Majsec K; Bolt EL; Ivančić-Baće I
    BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
    Heler R; Samai P; Modell JW; Weiner C; Goldberg GW; Bikard D; Marraffini LA
    Nature; 2015 Mar; 519(7542):199-202. PubMed ID: 25707807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of spacer acquisition by sequential assembly of the adaptation module in Synechocystis.
    Wu C; Tang D; Cheng J; Hu D; Yang Z; Ma X; He H; Yao S; Fu TM; Yu Y; Chen Q
    Nucleic Acids Res; 2021 Mar; 49(5):2973-2984. PubMed ID: 33619565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptation by Type V-A and V-B CRISPR-Cas Systems Demonstrates Conserved Protospacer Selection Mechanisms Between Diverse CRISPR-Cas Types.
    Wu WY; Jackson SA; Almendros C; Haagsma AC; Yilmaz S; Gort G; van der Oost J; Brouns SJJ; Staals RHJ
    CRISPR J; 2022 Aug; 5(4):536-547. PubMed ID: 35833800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.